Versanis Presents Data Demonstrating Bimagrumab Treatment Leads to Substantial Fat Mass Loss Coupled with Lean Mass Gain in Diabetic and Non-Diabetic Patients ...Middle East

Presentation at ENDO 2022 shows similar beneficial improvement in body composition irrespective of metabolic impairment Phase 2b obesity study of bimagrumab monotherapy and co-administration with incretin therapy to start later this year NEW YORK, June 11, 2022 /PRNewswire/ -- Versanis...

Hence then, the article about versanis presents data demonstrating bimagrumab treatment leads to substantial fat mass loss coupled with lean mass gain in diabetic and non diabetic patients was published today ( Saturday 11/06/2022 - 05:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Versanis Presents Data Demonstrating Bimagrumab Treatment Leads to Substantial Fat Mass Loss Coupled with Lean Mass Gain in Diabetic and Non-Diabetic Patients )

Also on site :

• List of all FIFA World Cup 2026 matches today & kick-off times (11 June)
• UN watchdog demands Iran provide information on nuclear stockpile
• SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit with the Schall Law Firm